Goldman Sachs’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $71.2M | Buy |
421,447
+120,541
| +40% | +$20.8M | 0.01% | 1284 |
|
|
2025
Q4 | $55M | Buy |
300,906
+76,767
| +34% | +$10.7M | 0.01% | 1440 |
|
|
2025
Q3 | $27.2M | Sell |
224,139
-4,065
| -2% | -$458K | ﹤0.01% | 1958 |
|
|
2025
Q2 | $23.8M | Sell |
228,204
-73,514
| -24% | -$7.78M | ﹤0.01% | 1979 |
|
|
2025
Q1 | $35.2M | Buy |
301,718
+84,151
| +39% | +$9.59M | 0.01% | 1496 |
|
|
2024
Q4 | $18.4M | Sell |
217,567
-145,058
| -40% | -$13.3M | ﹤0.01% | 2205 |
|
|
2024
Q3 | $32.6M | Sell |
362,625
-38,702
| -10% | -$3.38M | 0.01% | 1617 |
|
|
2024
Q2 | $32.3M | Buy |
401,327
+109,715
| +38% | +$8.12M | 0.01% | 1487 |
|
|
2024
Q1 | $23.3M | Buy |
291,612
+85,797
| +42% | +$7.2M | ﹤0.01% | 1711 |
|
|
2023
Q4 | $16.4M | Buy |
205,815
+46,566
| +29% | +$3.11M | ﹤0.01% | 2093 |
|
|
2023
Q3 | $11.1M | Buy |
159,249
+19,310
| +14% | +$1.44M | ﹤0.01% | 2301 |
|
|
2023
Q2 | $10.1M | Sell |
139,939
-129,381
| -48% | -$9.54M | ﹤0.01% | 2449 |
|
|
2023
Q1 | $16.6M | Buy |
269,320
+3,481
| +1% | +$229K | ﹤0.01% | 1980 |
|
|
2022
Q4 | $20.5M | Sell |
265,839
-253,425
| -49% | -$15.1M | 0.01% | 1932 |
|
|
2022
Q3 | $23.2M | Buy |
519,264
+141,927
| +38% | +$7.09M | 0.01% | 1745 |
|
|
2022
Q2 | $14.5M | Buy |
377,337
+319,200
| +549% | +$10.1M | ﹤0.01% | 2169 |
|
|
2022
Q1 | $2.41M | Sell |
58,137
-21,913
| -27% | -$679K | ﹤0.01% | 4095 |
|
|
2021
Q4 | $3.02M | Buy |
80,050
+36,341
| +83% | +$1.34M | ﹤0.01% | 3874 |
|
|
2021
Q3 | $1.44M | Buy |
43,709
+1,681
| +4% | +$65.5K | ﹤0.01% | 4468 |
|
|
2021
Q2 | $2.83M | Sell |
42,028
-100,662
| -71% | -$6.04M | ﹤0.01% | 3881 |
|
|
2021
Q1 | $8.08M | Sell |
142,690
-35,106
| -20% | -$2.47M | ﹤0.01% | 2738 |
|
|
2020
Q4 | $14.5M | Sell |
177,796
-152,661
| -46% | -$11.4M | ﹤0.01% | 2138 |
|
|
2020
Q3 | $23.5M | Sell |
330,457
-85,753
| -21% | -$6.68M | 0.01% | 1609 |
|
|
2020
Q2 | $34.2M | Buy |
416,210
+196,203
| +89% | +$15.1M | 0.01% | 1256 |
|
|
2020
Q1 | $12.9M | Buy |
220,007
+16,199
| +8% | +$1.32M | ﹤0.01% | 1868 |
|
|
2019
Q4 | $21.1M | Buy |
203,808
+173,588
| +574% | +$7.01M | 0.01% | 1812 |
|
|
2019
Q3 | $612K | Buy |
30,220
+8,228
| +37% | +$211K | ﹤0.01% | 4345 |
|
|
2019
Q2 | $566K | Sell |
21,992
-46,061
| -68% | -$923K | ﹤0.01% | 4329 |
|
|
2019
Q1 | $968K | Buy |
+68,053
| New | +$632K | ﹤0.01% | 4072 |
|
|
2018
Q1 | – | Sell |
-42,473
| Closed | -$238K | – | 5904 |
|
|
2017
Q4 | $238K | Buy |
+42,473
| New | +$214K | ﹤0.01% | 5322 |
|
|
2017
Q3 | – | Sell |
-67,618
| Closed | -$372K | – | 6652 |
|
|
2017
Q2 | $372K | Buy |
67,618
+36,698
| +119% | +$154K | ﹤0.01% | 5323 |
|
|
2017
Q1 | $121K | Buy |
+30,920
| New | +$148K | ﹤0.01% | 5976 |
|
|
2016
Q3 | – | Sell |
-17,854
| Closed | -$135K | – | 7010 |
|
|
2016
Q2 | $135K | Buy |
+17,854
| New | +$164K | ﹤0.01% | 5969 |
|
|
2016
Q1 | – | Sell |
-24,426
| Closed | -$226K | – | 7076 |
|
|
2015
Q4 | $226K | Buy |
+24,426
| New | +$215K | ﹤0.01% | 5599 |
|
Other funds holding AXSM
VPM
VCM
DTC
